Protagonist Therapeutics PTGX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's short-term investments?
- Protagonist Therapeutics (PTGX) reported short-term investments of $354.07M in Q1 2026.
- How has Protagonist Therapeutics's short-term investments changed year-over-year?
- Protagonist Therapeutics's short-term investments decreased by 18.5% year-over-year, from $434.71M to $354.07M.
- What is the long-term trend for Protagonist Therapeutics's short-term investments?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's short-term investments has grown at a 18.4% compound annual growth rate (CAGR), from $188.45M to $438.97M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.